Bio Micro Science
Minimally Invasive Catheter Solution for Heart and Brain
Company Overview
Snapshot
Founded in September 2023 by Eli Ben Haroosh and Asher Holzer, Bio Micro Science operates with 1–10 employees. The company is currently in its Pre-Funding stage, with one funding round initiated in August 2024, seeking seed capital to advance its pre-clinical research.
Business overview
Bio Micro Science is a Health Tech & Life Sciences company focused on developing innovative medical device solutions for heart and brain catheterization. The company's core technology involves unique, minimally invasive catheter devices, including "The Ninja" for heart disease treatment and "The Slider" for stroke treatment. Bio Micro Science targets the healthcare sector, specifically providers and the medical equipment industry, aiming to improve and streamline catheterization procedures.
Strategic signal
In July 2024, Bio Micro Science launched a seed funding round through the Exit Valley platform to complete pre-clinical research for its innovative catheter devices. This initiative signals the company's commitment to advancing its medical technology and addressing critical needs in heart disease and stroke treatment, positioning it for potential growth and market entry.
Log in to access full profile ›Company Intelligence Q&A
- What is Bio Micro Science's primary focus?
- Bio Micro Science is developing medical device solutions for heart and brain catheterization, utilizing unique technology for personal use.
- When was Bio Micro Science founded?
- Bio Micro Science was founded in September 2023.
- Who are the founders of Bio Micro Science?
- The company was co-founded by Eli Ben Haroosh, who serves as CEO, and Asher Holzer, who is a Director.
- What are the key products developed by Bio Micro Science?
- Bio Micro Science has developed two key products: "The Ninja," designed to improve treatment for heart disease, and "The Slider," aimed at improving treatment for stroke.
- What was a significant recent development for Bio Micro Science?
- In August 2024, Bio Micro Science initiated a seed funding round through the Exit Valley platform to complete pre-clinical research for its innovative catheter devices.